Left ventricular assist devices (LVADs) are an important therapeutic option for patients with end-stage heart failure waiting for heart transplantation or in older patients as definite therapy for heart failure. Interestingly, about 62% of patients receiving LVADs do not have an automatic implantable cardioverter-defibrillator (AICD) at the time of implantation, although these patients have increased risk of being confronted with dangerous arrhythmia. Therefore, an LVAD system including AICD function is a reasonable alternative for such heart failure patients thereby avoiding a second surgical intervention for AICD implantation. In this article, a newly developed system including LVAD and AICD function is introduced, and we also report its first in vitro testing.
CITATION STYLE
Aboud, A., Liebing, K., Abraham, C., Reil, J. C., Turkistani, Y., Eitz, T., … Morshuis, M. (2019). Defibrillator-Heart Pump: An Implantable Ventricular Assist Device With Integrated Defibrillator Component—The First In Vitro Testing. Surgical Innovation, 26(6), 720–724. https://doi.org/10.1177/1553350619862994
Mendeley helps you to discover research relevant for your work.